Investor Adage Capital Management, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Adage Capital Management, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-09-02 13G/A PRAX / Praxis Precision Medicines, Inc. 1,974,585 2,374,085
2025-08-12 13G/A AMLX / Amylyx Pharmaceuticals, Inc. 5,697,605 8,800,000
2025-08-12 13G/A TCRX / TScan Therapeutics, Inc. 1,350,000
2025-08-12 13G/A EYPT / EyePoint Pharmaceuticals, Inc. 5,750,000 6,800,000
2025-08-12 13G ADGM / Adagio Medical Holdings, Inc. 821,261
2025-08-12 13G DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) 14,614,449
2025-08-12 13G TNGX / Tango Therapeutics, Inc. 5,905,349
2025-08-12 13G/A IMUX / Immunic, Inc. 1,398,600 10,479,337
2025-08-12 13G/A JANX / Janux Therapeutics, Inc. 3,061,750 2,525,000
2025-08-12 13G/A SLNO / Soleno Therapeutics, Inc. 4,392,696 3,575,964
2025-08-12 13G/A CABA / Cabaletta Bio, Inc. 3,634,475 9,002,580
2025-08-12 13G/A SDRL / Seadrill Limited 4,200,535 3,138,286
2025-08-12 13G/A WVE / Wave Life Sciences Ltd. 12,516,500 15,016,500
2025-08-12 13G/A ENSC / Ensysce Biosciences, Inc. 74,711 74,711
2025-08-12 13G/A PRQR / ProQR Therapeutics N.V. 8,102,098 6,601,938
2025-08-12 13G/A PRAX / Praxis Precision Medicines, Inc. 1,742,758 1,974,585
2025-08-12 13G/A ZEO / Zeo Energy Corp. 760,000 760,000
2025-08-12 13G/A INZY / Inozyme Pharma, Inc. 0
2025-08-12 13G/A CDTX / Cidara Therapeutics, Inc. 990,000 1,100,000
2025-08-12 13G/A FULC / Fulcrum Therapeutics, Inc. 3,000,000 4,589,000
2025-08-12 13G/A CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 6,954,000 8,403,000
2025-08-12 13G/A ALGS / Aligos Therapeutics, Inc. 325,000 210,000
2025-06-20 13D/A 50,912
2025-05-12 13G/A PRQR / ProQR Therapeutics N.V. 9,602,280 8,102,098
2025-05-12 13G/A ACRS / Aclaris Therapeutics, Inc. 9,627,304 8,201,344
2025-05-12 13G/A SDRL / Seadrill Limited 3,429,169 4,200,535
2025-05-12 13G/A SLNO / Soleno Therapeutics, Inc. 3,322,146 4,392,696
2025-05-12 13G/A WVE / Wave Life Sciences Ltd. 9,703,351 12,516,500
2025-05-12 13G AMLX / Amylyx Pharmaceuticals, Inc. 5,697,605
2025-05-12 13G PRAX / Praxis Precision Medicines, Inc. 854,083 1,742,758
2025-05-12 13G CDTX / Cidara Therapeutics, Inc. 990,000
2025-05-12 13G SLDB / Solid Biosciences Inc. 1,754,159 6,729,484
2025-05-12 13G CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock) 6,954,000
2025-05-12 13G ENSC / Ensysce Biosciences, Inc. 74,711
2025-05-12 13G/A AEVA / Aeva Technologies, Inc. 1,401,454
2025-05-12 13G TRAW / Traws Pharma, Inc. 330,000
2025-05-12 13G/A URGN / UroGen Pharma Ltd. 2,928,086 1,277,000
2025-05-12 13G/A MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock) 8,503,780
2025-05-12 13G/A TARA / Protara Therapeutics, Inc. 2,250,000 0
2025-05-12 13G/A ABEO / Abeona Therapeutics Inc. 4,210,429 4,411,572
2025-05-12 13G/A LXEO / Lexeo Therapeutics, Inc. 2,209,615 237,953
2025-02-12 13G PRQR / ProQR Therapeutics N.V. 9,602,280
2025-02-12 13G MNPR / Monopar Therapeutics Inc. 599,195
2025-02-12 13G/A IMUX / Immunic, Inc. 5,594,406 1,398,600
2025-02-12 13G KPTI / Karyopharm Therapeutics Inc. 6,551,055
2025-02-12 13G/A ENGN / enGene Holdings Inc. 2,329,768 1,528,768
2025-02-12 13G/A LXEO / Lexeo Therapeutics, Inc. 2,597,736 2,209,615
2025-02-12 13G/A EYPT / EyePoint Pharmaceuticals, Inc. 3,791,420 5,750,000
2025-02-12 13G DYNX / Dynamix Corporation 1,350,000
2025-02-12 13G/A URGN / UroGen Pharma Ltd. 3,735,741 2,928,086
2025-02-12 13G ZVRA / Zevra Therapeutics, Inc. 3,650,000
2025-02-12 13G/A ALGS / Aligos Therapeutics, Inc. 218,813 325,000
2025-02-12 13G ACRS / Aclaris Therapeutics, Inc. 9,627,304
2025-02-12 13G SDRL / Seadrill Limited 3,429,169
2025-02-12 13G FULC / Fulcrum Therapeutics, Inc. 3,000,000
2025-02-12 13G TARA / Protara Therapeutics, Inc. 2,250,000
2025-02-12 13G JANX / Janux Therapeutics, Inc. 3,061,750
2025-02-12 13G STR / Sitio Royalties Corp. 6,263,396
2024-11-19 13G ZEO / Zeo Energy Corp. 760,000
2024-11-12 13G/A MGTX / MeiraGTx Holdings plc 5,229,099
2024-11-12 13G/A CABA / Cabaletta Bio, Inc. 3,634,475
2024-11-12 13G/A RZLT / Rezolute, Inc. 2,842,163
2024-11-12 13G/A GHLD / Guild Holdings Company 597,110
2024-11-12 13G/A AMAL / Amalgamated Financial Corp. 716,262
2024-11-12 13G/A PWP / Perella Weinberg Partners 1,037,615
2024-11-12 13G/A HOWL / Werewolf Therapeutics, Inc. 2,000,594
2024-11-12 13G/A CRBP / Corbus Pharmaceuticals Holdings, Inc. 528,937
2024-11-12 13G/A SVRA / Savara Inc. 6,753,701
2024-11-12 13G/A ANNX / Annexon, Inc. 3,485,931
2024-11-12 13G/A SLDB / Solid Biosciences Inc. 1,754,159
2024-11-12 13G HRTX / Heron Therapeutics, Inc. 8,850,000
2024-11-12 13G/A AURA / Aura Biosciences, Inc. 4,881,125
2024-11-12 13G/A SLNO / Soleno Therapeutics, Inc. 3,322,146
2024-11-12 13G/A VINP / Vinci Compass Investments Ltd. 0
2024-11-12 13G/A EYPT / EyePoint Pharmaceuticals, Inc. 5,156,299 3,791,420
2024-11-12 13G/A WVE / Wave Life Sciences Ltd. 9,703,351
2024-11-12 13G/A STRO / Sutro Biopharma, Inc. 2,250,132
2024-11-12 13G/A VERU / Veru Inc. 7,861,111
2024-11-12 13G/A NKTX / Nkarta, Inc. 3,600,000
2024-11-12 13G/A PRAX / Praxis Precision Medicines, Inc. 854,083
2024-11-12 13G/A VSTM / Verastem, Inc. 0
2024-11-12 13G ENGN / enGene Holdings Inc. 2,329,768
2024-11-12 13G URGN / UroGen Pharma Ltd. 3,735,741
2024-11-12 13G LXEO / Lexeo Therapeutics, Inc. 2,597,736
2024-11-12 13G/A KALV / KalVista Pharmaceuticals, Inc. 1,419,792
2024-11-12 13G ALGS / Aligos Therapeutics, Inc. 218,813
2024-11-12 13G/A MTEM / Molecular Templates, Inc. 0
2024-11-12 13G IMUX / Immunic, Inc. 5,594,406
2024-11-12 13G TENX / Tenax Therapeutics, Inc. 369,097
2024-11-04 13D GLYC / GlycoMimetics, Inc. 5,091,231
2024-10-22 13D/A ORKA / Oruka Therapeutics, Inc. 175,000
2024-06-03 13G/A ABEO / Abeona Therapeutics Inc. 4,210,429
2024-05-01 13G/A EYPT / EyePoint Pharmaceuticals, Inc. 5,156,299 5,156,299
2024-04-30 13G EYPT / EyePoint Pharmaceuticals, Inc. 5,156,299
2024-04-05 13D ABIO / ARCA biopharma, Inc. 1,200,000